Screener
Beta Bionics BBNX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
FAQ
- What is Beta Bionics's EPS (diluted)?
- Beta Bionics (BBNX) reported EPS (diluted) of -$0.53 in Q2 2026.
- How has Beta Bionics's EPS (diluted) changed year-over-year?
- Beta Bionics's EPS (diluted) decreased by 35.9% year-over-year, from -$0.39 to -$0.53.
- What is the long-term trend for Beta Bionics's EPS (diluted)?
- Over 2 years (2023 to 2025), Beta Bionics's EPS (diluted) has grown at a -51.7% compound annual growth rate (CAGR), from -$8.31 to -$1.94.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Beta Bionics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude